Khanna, D;
Furst, DE;
Clements, PJ;
Allanore, Y;
Baron, M;
Czirjak, L;
Distler, O;
... Denton, CP; + view all
(2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.
Journal of Scleroderma and Related Disorders
, 2
(1)
pp. 11-18.
10.5301/jsrd.5000231.
Preview |
Text
Denton_JSRD-MRSS 2017 Khanna Denton accepted ms.pdf - Accepted Version Download (155kB) | Preview |
Abstract
The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
Type: | Article |
---|---|
Title: | Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.5301/jsrd.5000231 |
Publisher version: | http://doi.org/10.5301/jsrd.5000231 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
URI: | https://discovery.ucl.ac.uk/id/eprint/1558610 |
Archive Staff Only
View Item |